The Dhaka-based Beximco, which counts Norges Bank as one of its investors, will sell remdesivir for about 6,000 taka ($71) a vial to private clinics but will give it free to state-run hospitals
Once the late stage trials begin, the company simultaneously will start working on the global manufacturing capabilities.
The company had posted a net profit of Rs 146.81 crore for the same period previous fiscal, GlaxoSmithKline Pharmaceuticals said in a BSE filing.
According to the agreement the companies Cipla, Hetero Labs, Jubilant Life Sciences, Mylan, and Pakistan based Ferozsons Labs, to manufacture and sell remdesivir in 127 countries
'Self-reliant India' package is around 10% of GDP; lockdown 4.0 is on with new guidelines
The rapid growth of the trade generics market which accounts for a third of pharma volumes is another trend which is impacting volume as well as overall growth of the branded segment
With public transport still not allowed in 130 red-zone districts, which comprise some of the economically important urban centres, people took out their private vehicles.
Inventory days have gone up from 31 days as on March 22 to 41 days as on April 22
New launches stagnate as fresh prescriptions dry up
Local drug makers start developing patented drug as govt too wishes to try it on Indians
Galaxy Surfactants, SRF, Aarti Industries among companies to benefit given supply of essential ingredients, alternative supply chain to China and weak crude oil prices
The rapid test uses a blood sample and gives results based on detecting the presence of certain antibodies that react to the coronavirus protein
ICMR on Saturday said all hospitalised patients who have pneumonia or severe acute respiratory illness will be tested for Covid-19.
Policymakers and pharma companies will have to work together to speed up trials of new vaccines and legislate to ensure essential drugs and tests are affordable and available
If the disruption spills beyond the next 9 to 12 months, some of the higher rated corporates could face downward pressure
The matter will come up again in court on Monday
HAL can make up to 50 per cent of bulk drugs if it is provided financial assistance to upgrade its infrastructure, the company said
Despite having good demand from across the markets, primarily due to lower prices and easy availability, India controls only 2.4 per cent of global pharma exports
Trivitron Healthcare currently has nine manufacturing facilities across five locations -- Chennai, Mumbai, Pune, Ankara and Helsinki
The company has filed an application before the directorate for investigation into the imports from these countries for imposing anti-dumping duty